BiotechTube
Home/ReST Therapeutics/Reina Benabou, MD, PhD
RB

Reina Benabou, MD, PhD

Chief Medical Officer

ReST Therapeutics

Therapeutic Areas

NeuropsychiatryPost-Traumatic Stress Disorder (PTSD)Alzheimer's Disease

ReST Therapeutics Pipeline

DrugIndicationPhase
RST-101Post-Traumatic Stress Disorder (PTSD) - Early TreatmentPreclinical
FENMAlzheimer's Disease / Post-Traumatic Stress DisorderPhase 1

Leadership Team at ReST Therapeutics

GR
Gilles Rubinstenn, PhD, MBA
Chief Innovation Officer, Chairman & Founder
AR
Anthony R. Franco, JD
General Manager
View full ReST Therapeutics profile